capital raising, page-10

There has been a lot of negative posts of late (me included) so I thought that I would give my optimistic guess as to what will happen next.

Early tomorrow, half yearly report published followed closely by the capital raising announcement which says capital is to be raised through Merck Research Ventures Fund. They will provide $12M in exchange for 20% stake in our HCV, neuropathic pain and NSCLC programs. This will cause no dilution to existing shareholders.

For Sale: Crystal balls $200 each, or there could be a great deal on a job lot tomorrow depending on what happens next. lol